Sudha Orthopaedic & Gynec Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.40 M
as on 13-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 M
as on 13-12-2024
- Revenue 15.82%
(FY 2022)
- Profit 26.58%
(FY 2022)
- Ebitda 180.51%
(FY 2022)
- Net Worth 36.98%
(FY 2022)
- Total Assets 15.27%
(FY 2022)
About Sudha Orthopaedic & Gynec Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹8.00 M.
Sudha Agrawal, Manish Agrawal, Madan Agarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100RJ2016PTC049509
- Company No.
049509
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sudha Orthopaedic & Gynec Hospital?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudha Agrawal  | Director | 05-Mar-2016 | Current |
| Manish Agrawal | Director | 05-Mar-2016 | Current |
| Madan Agarwal | Director | 05-Mar-2016 | Current |
| Manasi Agrawal | Director | 05-Mar-2016 | Current |
Financial Performance of Sudha Orthopaedic & Gynec Hospital.
Sudha Orthopaedic & Gynec Hospital Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.82% increase. The company also saw a substantial improvement in profitability, with a 26.58% increase in profit. The company's net worth Soared by an impressive increase of 36.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sudha Orthopaedic & Gynec Hospital?
Unlock access to Sudha Orthopaedic & Gynec Hospital's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Oct 2023 | ₹8.00 M | Open |
How Many Employees Work at Sudha Orthopaedic & Gynec Hospital?
Unlock and access historical data on people associated with Sudha Orthopaedic & Gynec Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sudha Orthopaedic & Gynec Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudha Orthopaedic & Gynec Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
